Personalized at-home neurofeedback compared to long-acting methylphenidate in children with ADHD: NEWROFEED, a European randomized noninferiority trial,Journal of Child Psychology and Psychiatry

当前位置： X-MOL 学术 › J. Child Psychol. Psyc. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Personalized at-home neurofeedback compared to long-acting methylphenidate in children with ADHD: NEWROFEED, a European randomized noninferiority trial
Journal of Child Psychology and Psychiatry ( IF 7.6 ) Pub Date : 2021-06-24 , DOI: 10.1111/jcpp.13462
Diane Purper-Ouakil _{1,

2} , Hilario Blasco-Fontecilla ₃ , Tomas Ros ₄ , Eric Acquaviva ₅ , Tobias Banaschewski ₆ , Sarah Baumeister ₆ , Elisa Bousquet ₁ , Aurore Bussalb ₇ , Marie Delhaye ₈ , Richard Delorme ₅ , Renate Drechsler ₉ , Allison Goujon ₁ , Alexander Häge ₆ , Anna Kaiser ₆ , Louis Mayaud ₇ , Konstantin Mechler ₆ , Caroline Menache ₁₀ , Olivier Revol ₁₁ , Friederike Tagwerker ₉ , Susanne Walitza _{9,

12,

13} , Anna Maria Werling ₉ , Stephanie Bioulac _{14,

15} , Daniel Brandeis _{6,

9,

12,

13}

Affiliation

Unit of Child and Adolescent Psychiatry (MPEA1), CHU Montpellier-Saint Eloi Hospital, University of Montpellier, Montpellier, France.
Development and Trajectories, INSERM CESP U 1018 Psychiatry, Montpellier, France.
Department of Psychiatry, IDIPHISA-Puerta de Hierro University Hospital, ITA-Consulting Salud Mental, CIBERSAM, University Autonoma of Madrid, Madrid, Spain.
Department of Neuroscience, Campus Biotech CISA - Université de Genève, Genève, Switzerland.
Child and Adolescent Psychiatry, Robert Debré Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Mannheim, Germany.
Mensia Technologies, Paris, France.
Child and Adolescent Psychiatry, Erasme Academic Hospital, Université Libre de Bruxelles, Bruxelles, Belgium.
Department of Child and Adolescent Psychiatry and Psychotherapy, Psychiatric Hospital, University of Zurich, Zurich, Switzerland.
Clinique des Grangettes, Chêne-Bougeries, Switzerland.
Unit of Child and Adolescent Psychiatry, Hospices civils de Lyon, Hôpital Femme Mère Enfant, Bron Cedex, France.
Neuroscience Center Zurich, University of Zurich and ETH Zurich, Zurich, Switzerland.
Zurich Center for Integrative Human Physiology, University of Zurich, Zurich, Switzerland.
SANPSY, USR 3413, CNRS, Bordeaux, France.
Clinique du Sommeil, CHU Pellegrin, Bordeaux Cedex, France.

Neurofeedback is considered a promising intervention for the treatment of attention-deficit hyperactivity disorder (ADHD). NEWROFEED is a prospective, multicentre, randomized (3:2), reference drug-controlled trial in children with ADHD aged between 7 and 13 years. The main objective of NEWROFEED was to demonstrate the noninferiority of personalized at-home neurofeedback (NF) training versus methylphenidate in the treatment of children with ADHD.

中文翻译：

与长效哌醋甲酯相比，ADHD 儿童的个性化家庭神经反馈：NEWROFEED，一项欧洲随机非劣效性试验

神经反馈被认为是治疗注意力缺陷多动障碍 (ADHD) 的一种有前途的干预措施。NEWROFEED 是一项针对 7 至 13 岁 ADHD 儿童的前瞻性、多中心、随机 (3:2) 参考药物对照试验。NEWROFEED 的主要目标是证明个性化的家庭神经反馈 (NF) 训练与哌醋甲酯在治疗多动症儿童方面的非劣效性。

更新日期：2021-06-24

点击分享查看原文

点击收藏

阅读更多本刊最新论文本刊介绍/投稿指南

全部期刊列表>>